Home › Biogen Rises on Data From Early-Stage Alzheimer's Drug Trial
 

Keywords :   


Biogen Rises on Data From Early-Stage Alzheimer's Drug Trial

2014-12-03 00:11:59| Agriculture - Topix.net

Biogen Idec Inc. shares rose after the company said its Alzheimer's drug showed promising early results and will be quickly moved into a final-stage trial. In a small, early stage trial, Biogen's drug BIIB037 reduced beta amyloid in the brain, said Doug Williams, executive vice president of research and development, at a Deutsche Bank conference in Boston today.

Tags: data trial drug rises

Category:Agriculture and Forestry

Latest from this category

All news
24.11Ag secretary nominee has long history with Trump
22.11Trump expected to tab Kelly Loeffler for Secretary of Agriculture
22.11Hay supply is likely up, but winter feed costs still matter
22.11Future plans for US SHIP and USDA's role explored
22.11Strategy for increasing feed efficiency for cows
22.11Top 3 myths of cattle marketing
22.11Carcass management workshop gets pork producers FAD prepared
22.11Are we close to eliminating Mycoplasma hyopneumoniae from the U.S. swine herd?
Agriculture and Forestry »
24.1120225//
24.112012()
24.11oasis 2022 morning
24.11Bianchi San marco xr3
24.11()
24.11PS2
24.11
24.11 HD DVD BOX
More »